Press Release

PCF4+ 2013 e-book now half price!

1st August 2014

PCF4+ 2013 e-book version of the PCF now only £15. PCF5 print edition and PCF5 e-book to be published in autumn 2014.

Read more

Welcome to the website provides essential independent information for health professionals about drugs used in palliative and hospice care. It includes unauthorized indications and routes, and details about the administration of multiple drugs by continuous subcutaneous infusion. Please see our example sections and testimonials.

Please register to obtain free access to most areas of the site, i.e. Latest additions, News, Bulletin board (for both drug and non-drug issues), syringe driver survey drug compatibility database (SDSD) and Document library. There is also a search facility for the whole site.

A subscription is required to access the on-line Palliative Care Formulary (PCF). This is based on the 4th UK edition published in October 2011. The on-line version will be regularly updated and will thus provide access to the most up to date content. To subscribe: first register, then log on and go to the Store. Before use, we recommend that you read Getting the most out of PCF.

With cumulative global sales of over 100,000, PCF is the established resource in its field and receives worldwide acclaim. Territorial specific editions of PCF are available in Canada, Germany, Japan and the USA.

A German language on-line PCF is available. Hier für Zugang klicken.

Find out how you can support the work of

Strong Opioid Booklet - Available to UK healthcare institutions

Calling all members

Please complete our short survey:

Domperidone - What is your experience?

Latest Additions

  • 31st July 2014
    Palliative Care Formulary updated monographs (July 2014) Read more
  • 22nd July 2014
    PCF Chapter 27: Anaphylaxis updated Read more


  • 19th September 2014
    Supplementary information on wholesale dealer and controlled drugs licences in England Read more
  • 9th September 2014
    Domperidone restricted to a POM Read more